Related articles
-
NewsA universal toolkit for editing bacterial DNA
A major collaboration involving nine labs has transferred a particularly useful DNA editing system from E. coli into 14 new species of bacteria, spanning three major branches of the bacterial family tree.
-
NewsCrab shell by-products could help regulate the marine lifetime of biodegradable plastics
Researchers show that crab shell by-products can reduce the breakdown rate of biodegradable plastics in seawater by altering the microbial communities that colonize their surfaces, known as the plastisphere.
-
NewsHow AI can help us count the ‘good’ viruses used in biopharmaceuticals
Researchers have developed a new methodology that uses artificial intelligence (AI) tools to identify and count target viruses more efficiently than previous techniques. The new approach can be used in applications such as pharmaceutical biomanufacturing.
More from News
-
NewsFrom precision intervention to a “virtual gut”: how close are we to predicting and steering the human microbiome?
A new review maps how multi-omics and machine learning could turn host-microbiome research from correlation hunting into actionable prediction and personalized therapy.
-
NewsAutomation platform enables high-resolution spatial mapping of microbial communities
Researchers have developed a sequential error-robust FISH spatial mapping platform (SEER-Map) which enables fully automated, high-multiplexity spatial profiling of complex microbial communities at single-cell resolution.
-
NewsResearchers deploy phage therapy in new frontier against antimicrobial resistant infectious diseases
A revelatory treatment for patients with life-threatening infectious diseases is being pioneered in Melbourne. VICPhage, a clinical partnership between The Alfred and Monash, is one of the first in Australia to offer end-to-end capacity in phage therapy to treat some of the most challenging infections.
No comments yet